Warren W Wasiewski MD
Head of Research and Development and Chief Medical Officer for BioBlast Pharma
Join to View Full Profile
500 University DrHershey, PA 17033
Phone+1 800-243-1455
Dr. Wasiewski is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Baylor College of MedicineFellowship, Child Neurology, 1986 - 1987- Baylor College of MedicineResidency, Neurology, 1984 - 1986
University at BuffaloResidency, Pediatrics, 1982 - 1984- Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 1982
Certifications & Licensure
PA State Medical License 1987 - 2026
American Board of Pediatrics Pediatrics
American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
Clinical Trials
- Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke Start of enrollment: 2005 Sep 01
- ASP-II: Ancrod Stroke Program: Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke Start of enrollment: 2006 Mar 01
- Compassionate Use of Stannsoporfin in Addition to Phototherapy to Reduce the Need for Exchange Transfusions in Term and Near-Term Infants Start of enrollment: 2003 Oct 01
Publications & Presentations
PubMed
- 35 citationsNeuromyelitis optica relapses: Race and rate, immunosuppression and impairmentGeorge Tackley, Fanny O’Brien, João Rocha, Mark Woodhall, Patrick Waters
Multiple Sclerosis and Related Disorders. 2016-05-01 - 36 citationsChallenges and opportunities in designing clinical trials for neuromyelitis opticaBrian G. Weinshenker, Gerard Barron, Jacinta M. Behne, Jeffery L. Bennett, Peter Chin
Neurology. 2015-04-28 - 34 citationsHome Time Is Extended in Patients With Ischemic Stroke Who Receive Thrombolytic Therapy A Validation Study of Home Time as an Outcome MeasureNishant K. Mishra, Ashfaq Shuaib, Patrick D. Lyden, Hans-Christoph Diener, James C. Grotta
Stroke. 2011-04-01
Press Mentions
Bio Blast Pharma Explodes on Positive ResultsMarch 16th, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
